372199-34-3

Basic information

• Product Name: Carbamic acid, [(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-, phenylmethyl ester
• Synonyms: benzyl [(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]carbamate;Z-tert-Leu-NH2
• CAS NO: 372199-34-3
• Molecular Formula: C14H20N2O3
• Molecular Weight: 264.324
• Mol File: 372199-34-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-, phenylmethyl ester(372199-34-3)
• EPA Substance Registry System: Carbamic acid, [(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-, phenylmethyl ester(372199-34-3)

Safety Data

• Hazardous Substances Data: 372199-34-3(Hazardous Substances Data)

Upstream product

• 62965-37-1 (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid dicyclohexylammonium salt 
• 62965-10-0 (S)-N-carbobenzoxy-tert-butylleucine 

Downstream Products

• 586972-70-5 2R-(2,2-dimethyl-5-oxo-[1,3]dioxolan-4S-yl)-4-methyl-pentanoic acid [2,2-dimethyl-1S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propyl]-amide 
• 586972-67-0 [2,2-dimethyl-1S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propyl]-carbamic acid benzyl ester 
• 586972-66-9 [1S-(N-hydroxycarbamimidoyl)-2,2-dimethyl-propyl]-carbamic acid benzyl ester 
• 1185282-00-1 ADB-FUBINACA 
• 910377-22-9 benzyl [(1S)-2,2-dimethyl-1-(2H-tetrazol-5-yl)propyl]carbamate 
• 62965-57-5 (S)-(+)-2-amino-3,3-dimethylbutanamide 
• 586972-65-8 (1S-cyano-2,2-dimethyl-propyl)-carbamic acid benzyl ester 

Relevant articles and documents

INDAZOLE DERIVATIVES

This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a

SUBSTITUTED IMIDAZOHETEROCYCLES

The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I Also provided are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis and treatment of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation and pruritis.

METALLOPROTEINASE INHIBITORS

Compounds formula (IA) or (IB); wherein W represents HO(C=0)-, HONH(C=0)- or H(C=O)N(OH)-; X represents -O- or -S-; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metalloproteinases, in particular MMP9 and/or MMP12.